Loading organizations...
Loading organizations...
Biotechnology company using stem cell technology for drug discovery.
Ncardia has raised $80.1M across 4 funding rounds.
Ncardia has raised $80.1M in total across 4 funding rounds.
Ncardia has raised $80.1M in total across 4 funding rounds.
Ncardia's investors include Geoffrey Glass, Marc Foidart, InnovationQuarter, Sambrinvest, SFPI-FPIM, SRIW, Vesalius Biocapital, Alain Parthoens, Gerty Holla, Philippe Degive.
Ncardia has raised $80.1M across 4 funding rounds. Most recently, it raised $60.0M Other Equity in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 16, 2021 | $60.0M Other Equity | Geoffrey Glass | |
| Nov 17, 2017 | $12.4M Series B | Marc Foidart | InnovationQuarter, Sambrinvest, SFPI-FPIM, SRIW, Vesalius Biocapital |
| Apr 1, 2017 | $2.7M Other Equity | Sambrinvest, SFPI-FPIM | |
| Oct 24, 2014 | $5.1M Series A | Alain Parthoens | Gerty Holla, Philippe Degive |